Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed question first answered answering member label
tabling member	label

Search

1716362

	registered interest
	date	08/05/2024
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Lung Cancer: Artificial Intelligence
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 7 May 2024 to Question 24269 on Lung Cancer: Artificial Intelligence, which (a) NHS trusts have and (b) imaging network has not received funding.
	tabling member constituency	Hove
	tabling member printed	Peter Kyle
	uin	25291
	answer	answer is ministerial correction date of answer 13/05/2024 answer text <p>Since the initial announcements regarding funding for National Health Service trusts to integrate artificial intelligence into lung cancer imaging, adjustments have been made to the list of participants. Three trusts have withdrawn from the initiative, and five additional trusts have been onboarded, due to the inclusion of a new imaging network. As a result, as set out in the answer of 7 May 2024, there are now 66 trusts across 12 imaging networks that are participating in this initiative.</p><p>In the answer of 7 May 2024, 63 out of 66 trusts, in 11 of 12 imaging networks, had received funding. It is now confirmed that all 66 trusts in the 12 imaging networks participating have received or are in the process of receiving funding. These trusts are currently implementing artificial intelligence technologies to enhance diagnostic capabilities in lung cancer, consistent with the Government's commitment to advancing healthcare technology across the NHS.</p> answering member constituency Pendle answering member printed Andrew Stephenson question first answered 13/05/2024 08:24:50 answering member 4044 label Biography information for Andrew Stephenson
	tabling member	4505 label Biography information for Peter Kyle

1716421

	registered interest
	date	08/05/2024
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Cancer: Drugs
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what discussions she (a) has had and (b) plans to have with (i) charities and (ii) other organisations working to secure UK access to new drugs for (A) incurable, (B) relapsing and (C) remitting cancers such as myeloma.
	tabling member constituency	Birmingham, Yardley
	tabling member printed	Jess Phillips
	uin	25238
	answer	answer is ministerial correction date of answer 13/05/2024 answer text <p>Department ministers and officials regularly meet with a range of organisations, with an interest in securing patient access to new cancer medicines. The National Institute for Health and Care Excellence (NICE) is the body that develops authoritative, evidence-based guidance for the National Health Service on whether new licensed medicines should be routinely funded by the NHS, based on an assessment of their costs and benefits, including medicines for myeloma. The NICE aims to publish guidance on all new medicines close to the point of licensing wherever possible, and has recommended many cancer medicines for NHS use that are now available to NHS patients, including through the Cancer Drugs Fund.</p> answering member constituency Pendle answering member printed Andrew Stephenson question first answered 13/05/2024 08:43:01 answering member 4044 label Biography information for Andrew Stephenson
	tabling member	4370 label Biography information for Jess Phillips

1716422

	registered interest
	date	08/05/2024
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Cancer: Medical Treatments
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, whether she (a) has had discussions and (b) plans to have discussions with the National Institute for Health and Care Excellence on (i) its use of the new severity modifier and (ii) how it (A) measures and (B) reports the impact of the modifier on approval of treatments for (1) cancers, (2) relapsing and remitting conditions and (3) conditions that are more prevalent in older people.
	tabling member constituency	Birmingham, Yardley
	tabling member printed	Jess Phillips
	uin	25239
	answer	answer is ministerial correction date of answer 13/05/2024 answer text <p>The Department regularly meets with colleagues in the National Institute for Health and Care Excellence (NICE) to discuss a range of issues, including in relation to the NICE’s methods for the evaluation of medicines. In 2022, the NICE introduced a number of changes to make its methods and processes fairer, faster, and more consistent. This includes the introduction of a broader severity modifier, in place of the end-of-life modifier. Since the changes were introduced, 79% of the NICE’s appraisals of cancer medicines carried out under the updated methods have recommended the use of the treatment for some or all of the eligible patient population, either for routine use or use through the Cancer Drugs Fund. The approval rate for all cancer appraisals carried out since 2009, when the end-of-life modifier was introduced, is 78%.</p> answering member constituency Pendle answering member printed Andrew Stephenson question first answered 13/05/2024 08:48:27 answering member 4044 label Biography information for Andrew Stephenson
	tabling member	4370 label Biography information for Jess Phillips

1716479

	registered interest
	date	08/05/2024
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Air Pollution: Health
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, whether her Department has made an assessment of the potential impact of household air pollution on (a) health outcomes and (b) NHS capacity and resources.
	tabling member constituency	Huddersfield
	tabling member printed	Mr Barry Sheerman
	uin	25168
	answer	answer is ministerial correction date of answer 13/05/2024 answer text <p>The UK Health Security Agency published a study quantifying the health burden in the population of England from key respiratory illness or conditions associated with residential exposures to damp, mould, and formaldehyde. In 2019, the presence of damp, mould, or both was associated with approximately 5,000 cases of asthma, and approximately 8,500 lower respiratory infections among children and adults. Residential formaldehyde exposure was associated with approximately 4,000 cases of childhood asthma among children.</p><p>Exposure to indoor air pollutants can trigger or exacerbate asthma, other respiratory or cardiovascular conditions, and may even have carcinogenic effects. Damp and mould have been associated with respiratory health outcomes, such as exacerbation of asthma, respiratory infections, and allergies. The National Health Service has not made an assessment of the potential impact of household air pollution on NHS capacity and resources.</p> answering member constituency Lewes answering member printed Maria Caulfield question first answered 13/05/2024 16:57:55 answering member 4492 label Biography information for Maria Caulfield
	tabling member	411 label Biography information for Mr Barry Sheerman

1716480

	registered interest
	date	08/05/2024
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Air Pollution: Monitoring
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, whether he has made an assessment with Cabinet colleagues of the potential (a) viability and (b) merits of creating a national indoor air quality observatory to monitor (i) levels and (ii) the potential health effects of indoor air pollution.
	tabling member constituency	Huddersfield
	tabling member printed	Mr Barry Sheerman
	uin	25169
	answer	answer is ministerial correction date of answer 13/05/2024 answer text <p>The Department continues to work collaboratively across the Government to address the impact of air pollution. We are taking significant and wide-ranging action to drive improvements to air quality, as set out in the Department for Environment, Food and Rural Affairs’ Environmental Improvement Plan. The United Kingdom Health Security Agency’s (UKHSA) Cleaner Air Programme also aims to help reduce people’s exposure to air pollution, tackle disparities in exposure, and improve outcomes for all, including through increasing the evidence base and improving awareness and understanding of the health impacts of air pollution. The UKHSA has published a study quantifying the health burden in the population of England from key respiratory conditions associated with residential exposures to damp, mould, and formaldehyde.</p> answering member constituency Lewes answering member printed Maria Caulfield question first answered 13/05/2024 17:02:17 answering member 4492 label Biography information for Maria Caulfield
	tabling member	411 label Biography information for Mr Barry Sheerman

1716530

	registered interest
	date	08/05/2024
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Musculoskeletal Disorders: Research
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what steps she is taking to help improve the (a) quality, (b) coverage, (c) availability and (d) use of musculoskeletal data.
	tabling member constituency	York Central
	tabling member printed	Rachael Maskell
	uin	25259
	answer	answer is ministerial correction date of answer 13/05/2024 answer text <p>The Office for Health Improvement and Disparities produces annual musculoskeletal health local profiles, designed to bring together meaningful data on a single platform, to enable the commissioning of high-value musculoskeletal services. Data is provided in a user-friendly format, to help local government and health services. They are regularly updated with relevant indicators, most recently in January 2024.</p> answering member constituency Pendle answering member printed Andrew Stephenson question first answered 13/05/2024 16:11:48 answering member 4044 label Biography information for Andrew Stephenson
	tabling member	4471 label Biography information for Rachael Maskell

1716532

	registered interest
	date	08/05/2024
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Joint Replacements: Surgery
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, how many and what proportion of people received treatment for (a) knee and (b) hip replacements in surgical hubs in each of the last 12 months.
	tabling member constituency	York Central
	tabling member printed	Rachael Maskell
	uin	25261
	answer	answer is ministerial correction date of answer 13/05/2024 answer text <p>NHS England has introduced specific hub-level data site codes for all operational hubs in 2023, with 89% of the 101 operational hubs now reporting data against these codes. However, as many of the hubs have only recently introduced the data codes, NHS England have limited data available for the last 12 months, and much of this new data submission is still being validated. Therefore, NHS England currently do not have reliable, validated hub-specific data about specific procedures undertaken in hubs.</p> answering member constituency Pendle answering member printed Andrew Stephenson question first answered 13/05/2024 08:52:57 answering member 4044 label Biography information for Andrew Stephenson
	tabling member	4471 label Biography information for Rachael Maskell

1716533

	registered interest
	date	08/05/2024
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Medical Records: Databases
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what progress her Department has made on ensuring all NHS trusts have electronic patient records by March 2026.
	tabling member constituency	York Central
	tabling member printed	Rachael Maskell
	uin	25262
	answer	answer is ministerial correction date of answer 13/05/2024 answer text <p>The aim of the Frontline Digitisation programme is for all secondary care National Health Service trusts to have an Electronic Patient Record (EPR) system that meets our standards. The Government's 2023 mandate for NHS England set a target for 90% of NHS trusts to have an EPR system in place by December 2023, which has been met. The programme is forecasting to achieve 98% EPR coverage by March 2026, with the remaining 2% of NHS trusts advancing in their plans for an EPR.</p> answering member constituency Pendle answering member printed Andrew Stephenson question first answered 13/05/2024 12:41:52 answering member 4044 label Biography information for Andrew Stephenson
	tabling member	4471 label Biography information for Rachael Maskell

1716534

	registered interest
	date	08/05/2024
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Surgery: Waiting Lists
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what steps her Department is taking to help reduce regional variations in the length of NHS elective care waiting lists.
	tabling member constituency	York Central
	tabling member printed	Rachael Maskell
	uin	25263
	answer	answer is ministerial correction date of answer 13/05/2024 answer text <p>Published management information from NHS England estimates that as of April 2024, three quarters of those waiting for 65 weeks are concentrated in 41 trusts. The National Health Service and Department are providing targeted regional and national intervention to these specific trusts with the largest backlogs, through a programme of challenge and support.</p> answering member constituency Pendle answering member printed Andrew Stephenson question first answered 13/05/2024 17:05:22 answering member 4044 label Biography information for Andrew Stephenson
	tabling member	4471 label Biography information for Rachael Maskell

1716535

	registered interest
	date	08/05/2024
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Asthma
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what assessment she has made of trends in the level of asthma (a) acute admissions and (b) deaths in the last 12 months.
	tabling member constituency	York Central
	tabling member printed	Rachael Maskell
	uin	25264
	answer	answer is ministerial correction date of answer 13/05/2024 answer text <p>NHS England has advised that admissions data for asthma show that it follows the seasonal pattern seen in past years of falling, lower rates in the spring and summer months, and increasing, higher rates in the winter months. There is no published mortality data for asthma available for the past 12 months. The most recent data published by the Office for National Statistics and NHS England covers the period up to 2022.</p> answering member constituency Faversham and Mid Kent answering member printed Helen Whately question first answered 13/05/2024 19:06:31 answering member 4527 label Biography information for Helen Whately
	tabling member	4471 label Biography information for Rachael Maskell